Seres Therapeutics (MCRB)

• Market cap: $54.2M
• 1 day: -8.35%
• 5 days: -26.8%
• 1 month: -0.36%
• 3 months: -34.73%
• 6 months: -64.93%
• Year to date: -63.04%
• 1 year: -62.29%
• 5 years: -98.66%
• 10 years: -99.12%
• Sector: Healthcare
• Industry: Biotechnology

About: Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Employees: 66